Cannabis Law Report

DECEMBER 17, 2021

Deletion Syndrome – Global Market Insights, Epidemiology and Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Country-Wise Epidemiology.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Cannabis Law Report

JUNE 30, 2021

According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

OCTOBER 1, 2021

We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. billion in 2019 and projected to reach near US$25 billion by 2030. billion industry by 2027.

Treatment 52

Treatment Conditions Media 52

Cannabis Law Report

FEBRUARY 3, 2022

DUBLIN–(BUSINESS WIRE)–The “Global Cannabis Market- Market Size & Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global cannabis market in the COVID-19 period has been estimated to value USD 25,650.4 million by 2030 at a CAGR of 23.9%, 2021-2030.

Indica 52

Indica Oil Legalization Research and Development 52

MGC Pharma

FEBRUARY 22, 2018

According to the Australian Bureau of Statistics, the number of people aged 65 years or older is expected to exceed the number of children aged 14 and below by as soon as 2030. of respondents who received Medical Cannabis treatment reported improvement in their condition and significant reductions to pain levels.

Research and Development 100

Research and Development Pharmaceutical Chronic Pain Treatment 100

Cannabis Law Report

JUNE 20, 2021

PUBLISHER: CANNABIS LAW REPORT. In 2010, the direct and indirect cost of mental health conditions worldwide was estimated to be $2.5 trillion by 2030. We believe psychedelics will expand treatment options and transform the outdated system. trillion — numbers which are projected to skyrocket to $6.0 About Palo Santo .

Research and Development 98

Research and Development Therapy Treatment Access 98

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. But, of course, the growth in the market will depend mainly on accurately diagnosing patients with certain mental illnesses and successfully treating those conditions with psychedelics.

Research and Development 105

Research and Development Data Conditions Therapy 105